CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Strategy Officer sold 300,000 shares at $2.26 ($676,920)
- 4 Open-market buy President/Secretary bought 72,000 shares at $2.75 ($198,000)
- 4 Open-market buy President/Secretary bought 72,000 shares at $2.75 ($198,000)
- 4 Open-market buy Director bought 36,000 shares at $2.75 ($99,000)
- 4 Open-market buy CEO bought 72,000 shares at $2.75 ($198,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $2.77 ($27,700)
- 4 Open-market buy CEO bought 35,000 shares at $2.74 ($95,900)
- 4 Open-market buy President/Secretary bought 10,000 shares at $2.93 ($29,300)
- 4 Open-market buy Director bought 35,000 shares at an average $2.83 ($98,900)
- 4 Open-market buy Director bought 3,144 shares at $3.18 ($9,998)
- 4 Open-market buy President/Secretary bought 15,000 shares at $3.16 ($47,400)
- 4 Open-market buy Director bought 5,000 shares at $3.04 ($15,200)
- 4 Open-market buy Director bought 10,000 shares at $2.87 ($28,700)
Page 8 of 22 · 428 filings